Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse

Inflammatory Bowel Diseases

Volumn 5, Issue 2, 1999, Pages 85-91

  Hilsden, Robert J ^a   Meddings, Jon B ^b   Hardin, James ^b   Gall, D Grant ^b   Sutherland, Lloyd R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Crohn's disease; Diamine oxidase activity; Intestinal permeability; Relapse prediction

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); DIAGNOSTIC AGENT; HEPARIN;

ADULT; ARTICLE; BLOOD; COHORT ANALYSIS; CROHN DISEASE; FEMALE; HUMAN; INTESTINE ABSORPTION; MALE; PERMEABILITY; PHYSIOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RECURRENT DISEASE; TIME;

ADULT; AMINE OXIDASE (COPPER-CONTAINING); COHORT STUDIES; CROHN DISEASE; FEMALE; HEPARIN; HUMANS; INTESTINAL ABSORPTION; MALE; PERMEABILITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS;

EID: 0033125309     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199905000-00003     Document Type: Article

References (21)

1. Murphy MS, Eastham EJ, Nelson R, Pearson AD, Laker MF. Intestinal permeability in Crohn's disease. Arch Dis Child 1989;64: 321-5.
2. Koltun WA, Tilberg AF, Page MJ, Poritz LS. Bowel permeability is improved in Crohn's disease after ileocolectomy. Dis Colon Rectum 1998;41:687-90.
3. Sanderson IR, Boulton P, Menzies I, Walker-Smith JA. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut 1987;28:1073-6.
4. Wyatt J, Vogelsang H, Hübl W, Waldhöer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993;341:1437-9.
5. Peeters M, Ghoos Y, Maes B, Hiele M, Geboes K, Vantrappen G, Rutgeerts P. Increased permeability of macroscopically normal small bowel in Crohn's disease. Dig Dis Sci 1994;39:2170-6.
6. Oberhuber G, Puspok A, Gesterreicher C, Novacek G, Zauner C, Burghuber M, Vogelsang H, Potzi R, Stolte M, Wrba F. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 1997;112:698-706.
7. Wyatt J, Oberhuber G, Pongratz S, Puspok A, Moser G, Novacek G, Lochs H, Vogelsang H. Increased gastric and intestinal permeability in patients with Crohn's disease. Am J Gastroenterol 1997; 92:1891-6.
8. D'Agostino L, Daniele B, Pallone F, Pignata S, Leoni M, Mazzacca G. Postheparin plasma diamine oxidase in patients with small bowel Crohn's disease. Gastroenterology 1988;95:1503-9.
9. Shakir KMM, Margolis S, Baylin SB. Localization of histaminase (diamine oxidase) in rat small bowel intestinal mucosa: site of release by heparin. Biochem Pharmac 1977;26:2343-7.
10. White AR, Baylin SB, Olivecrona T, Beaven MA. Binding of diamine oxidase activity to rat and guinea pig microvascular endothelial cells. J Clin Invest 1985;76:93-100.
11. D'Agostino L, Pignata S, Daniele B, et al. Postheparin plasma diamine oxidase values in the follow-up of patients with small bowel Crohn's disease. Gut 1991;32:932-5.
12. Best WR, Becktel JM, Singleton JW. Development of a Crohn's Disease Activity Index. Gastroenterology 1976;70:439-44.
13. Hilsden RJ, Meddings JB, Sutherland LR. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology 1996;110:1395-403.
14. Sutherland LR, Verhoef M, Wallace JL, Van Rosendaal G, Crutcher R, Meddings JB. A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet 1994;343:998-1000.
15. Thompson JS, Burnett DA, Cormier RA, Vaughan WP. Plasma postheparin diamine oxidase activity. Development of a simple technique of assessing Crohn's disease. Dis Colon Rectum 1988; 31:529-32.
16. D'Inca R, Di Leo V, Corrao G, et al. Intestinal permeability predicts the clinical course in Crohn's disease patients in remission: comparison with inflammatory indexes. Gastroenterology 1998; 114:A966.
17. Arnott IDR, Ghosh S, Ferguson A. Abnormal intestinal permeability predicts relapse in patients with inactive Crohn's disease. Gastroenterology 1998;114:A923.
18. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-81.
19. Present DH. The prevention of Crohn's disease after surgery: metronidazole is a small but continuous medical advancement. Gastroenterology 1995;108:1935-8.
20. Steinhart AH, Hemphill D, Greenberg GR. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis. Am J Gastroenterol 1994;89:2116-24.
21. Brignola C, Campieri M, Farruggia P, Tragnone A, Pasquali S, Iannone P, Lanfranchi GA, Barbara L. The possible utility of steroids in the prevention of relapses of Crohn's disease in remission. A preliminary study. J Clin Gastroenterol 1988;10:631-4.